Gut health depends on more than digestion. The intestinal lining, immune system, microbiome, nervous system, and daily habits all work together to influence comfort, regularity, nutrient absorption, and resilience.
Peptides are gaining attention because they act as signaling molecules rather than simply adding another vitamin or probiotic. For gut health, KPV and BPC-157 stand out most: KPV is centered on inflammatory signaling, while BPC-157 is associated with tissue protection and repair. Other peptides have narrower uses, including larazotide for intestinal tight-junction research and teduglutide for medically diagnosed short bowel syndrome.
Here is how the leading gut peptides compare and how to decide which approach best matches your goals.
For most people exploring peptide therapy for digestive wellness, the useful comparison is KPV vs. BPC-157. The better choice depends on whether the main priority is calming inflammatory signaling or supporting tissue repair.
KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. Its name comes from those amino acids: lysine, proline, and valine.
KPV is especially interesting for the gut because research connects it with inflammatory signaling in intestinal epithelial and immune cells. In experimental colitis models, KPV reduced intestinal inflammation after being transported into cells through PepT1, a peptide transporter that becomes more active in the colon during inflammation.
KPV is commonly discussed for:
Its focused anti-inflammatory profile makes KPV a strong starting point when digestive symptoms tend to flare with stress, food triggers, or other inflammatory patterns. Bowery Clinic offers KPV troches through a clinician-guided program that includes an individual health review and treatment plan.
BPC-157 is a synthetic 15-amino-acid peptide based on a protective compound found in gastric juice. Much of its popularity comes from its connection to both digestive health and whole-body tissue recovery.
In preclinical research, BPC-157 has supported the integrity and healing of tissues throughout the gastrointestinal tract, including the stomach and intestines. Researchers have explored several related mechanisms:
BPC-157 may be a good fit when the goal is broader digestive recovery, particularly when gut concerns overlap with training, connective-tissue recovery, or frequent NSAID use. Its whole-body repair profile distinguishes it from the more inflammation-focused KPV.
Read our complete guide to BPC-157 benefits for a closer look at its gut, tendon, ligament, and recovery applications.
KPV and BPC-157 are complementary rather than interchangeable.
Think of KPV as the calming peptide and BPC-157 as the repair peptide. A clinician can help determine whether one pathway is the clear priority or whether a broader strategy makes more sense.
Larazotide acetate is an oral peptide designed to influence tight junctions—the protein structures that regulate what passes between cells in the intestinal lining.
It has primarily been studied in people with celiac disease who continue to experience symptoms despite following a gluten-free diet. In a randomized trial of larazotide acetate, a low dose reduced symptom days and abdominal pain compared with placebo. This makes larazotide one of the most directly studied peptides in the intestinal-permeability conversation.
Larazotide remains a specialized investigational therapy rather than a general gut-health product. It is valuable to know about because it shows how peptide signaling can target the intestinal barrier with precision.
Teduglutide is an analog of glucagon-like peptide 2, a hormone naturally produced in the lower gastrointestinal tract. It supports intestinal growth and absorption.
Unlike wellness-oriented peptides, teduglutide has a very specific role: it is FDA-approved for adults and children aged one year and older with short bowel syndrome who depend on parenteral support. It can improve the intestine's ability to absorb fluids and nutrients.
Teduglutide demonstrates the real therapeutic power of gut peptides, but it is not intended for occasional bloating, general digestive wellness, or routine intestinal support.
Collagen peptides are hydrolyzed protein fragments available as powders and drinks. They provide glycine, proline, and hydroxyproline—amino acids used in connective tissues throughout the body.
Collagen can be an easy way to increase protein intake, but it works differently from targeted signaling peptides such as KPV and BPC-157. It is better viewed as a nutritional building block than a treatment for gut inflammation or intestinal permeability.
For everyday use, choose a product that:
“Leaky gut” is a popular term for increased intestinal permeability. The intestinal barrier normally controls what passes from the digestive tract into circulation. Stress, infections, alcohol, certain medications, and inflammatory digestive conditions can affect that barrier.
KPV is relevant because it targets inflammatory signaling in intestinal cells. BPC-157 is relevant because it has been studied for mucosal protection and repair throughout the gastrointestinal tract. Larazotide is the most directly focused on tight-junction regulation, although its clinical research has centered on celiac disease.
The best strategy also addresses the reason the barrier is under stress. Peptides work best as part of a complete plan that includes food quality, sleep, stress management, and appropriate evaluation of persistent symptoms.
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) sound similar but are different conditions.
KPV is frequently discussed in relation to inflammatory bowel pathways because of its activity in experimental colitis models. BPC-157 has also been studied across models of gastrointestinal inflammation and injury. For someone with an established digestive diagnosis, peptide therapy should complement—not replace—the care plan created with their gastroenterology team.
The gut responds best to a consistent environment. Whether or not you use peptides, focus on the fundamentals that help the intestinal lining and microbiome function well:
Persistent pain, bleeding, unexplained weight loss, fever, or symptoms that wake you at night deserve direct medical evaluation.
Start with the result you want:
At Bowery Clinic, a licensed provider reviews your digestive concerns, health history, medications, and goals before recommending a personalized peptide plan. Treatments are prescribed for eligible patients and fulfilled through licensed U.S. compounding pharmacies.
KPV is the strongest all-around choice for people focused on inflammatory balance and intestinal-barrier support. BPC-157 stands out when the goal centers on protecting and repairing gastrointestinal tissue.
KPV has the more focused anti-inflammatory profile, while BPC-157 has the broader repair profile. Your symptom pattern and goals determine which is the better fit.
They may be discussed together because they approach gut health through complementary pathways: KPV for inflammatory signaling and BPC-157 for tissue protection and recovery. A clinician can personalize the route, timing, and overall plan.
BPC-157 is widely studied for gastric and intestinal mucosal protection in preclinical models. KPV and larazotide are also relevant to intestinal-barrier function through different mechanisms.
Collagen peptides provide amino acids used in connective tissue and can support overall protein intake. They are useful nutritional support but are not equivalent to targeted peptides such as KPV or BPC-157.
The best peptides for gut health depend on the goal. KPV is the leading option for inflammatory balance and intestinal-barrier support. BPC-157 is the leading option for gut-lining protection, tissue repair, and broader recovery. Larazotide and teduglutide show how precisely peptides can target intestinal function in specialized settings.
For a personalized starting point, explore Bowery Clinic's KPV and BPC-157 programs and complete a clinician review to see which approach best matches your digestive-health goals.
